Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Jul 18;1813(1):152. doi: 10.1007/s40278-020-80909-3

Metoprolol

Lack of efficacy in ventricular tachycardia: case report

PMCID: PMC7366447

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

  • * death

  • * life-threatening

  • * hospitalisation

  • * disability

  • * congenital anomaly

  • * other medically important event

A 74-year-old man exhibited lack of efficacy during treatment with metoprolol for ventricular tachycardia.

The man was admitted to hospital due to haemodynamically unstable new-onset ventricular tachycardia of 12 hours duration. Then, he self-administered oral metoprolol 200mg. However, the therapy was unsuccessful, and arrhythmia was electrically cardioverted with subsequent symptomatic bradycardia and hypotension. On the following day of hospital admission, a recurrence of ventricular tachycardia occurred. He received unspecified magnesium substitution and amiodarone, and his rhythm stabilised. On the sixth day of hospitalisation, PCR showed positive results for SARS-CoV-2. Thus, he received a single 500mg dose of azithromycin and a single 75mg dose of oseltamivir. On the seventeenth day, reverse PCR showed positive results for SARS-CoV-2.

Reference

  1. Warchol I, et al. Terra incognita: Clinically suspected myocarditis in a patient with severe acute respiratory syndrome coronavirus 2 infection. Polskie Archiwum Medycyny Wewnetrznej 130: 446-448, No. 5, 29 May 2020. Available from: URL: 10.20452/pamw.15309 [DOI] [PubMed]

Articles from Reactions Weekly are provided here courtesy of Nature Publishing Group

RESOURCES